Annual Drug Patent Expirations for LYNPARZA
Lynparza is a drug marketed by Astrazeneca and is included in two NDAs. It is available from one supplier. There are eleven patents protecting this drug.
Drug patent litigation for LYNPARZA.
This drug has two hundred and fifty-seven patent family members in fifty-one countries.
The generic ingredient in LYNPARZA is olaparib. One supplier is listed for this compound. Additional details are available on the olaparib profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
